BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chow EJ, Doyle JD, Uyeki TM. Influenza virus-related critical illness: prevention, diagnosis, treatment. Crit Care 2019;23:214. [PMID: 31189475 DOI: 10.1186/s13054-019-2491-9] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 17.7] [Reference Citation Analysis]
Number Citing Articles
1 Kato M, Saisho Y, Tanaka H, Bando T. Effect of peramivir on respiratory symptom improvement in patients with influenza virus infection and pre-existing chronic respiratory disease: Findings of a randomized, open-label study. Influenza Other Respir Viruses 2021;15:132-41. [PMID: 32677375 DOI: 10.1111/irv.12788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Chow EJ, Rolfes MA, Carrico RL, Furmanek S, Ramirez JA, Ferdinands JM, Fry AM, Patel MM. Vaccine Effectiveness Against Influenza-Associated Lower Respiratory Tract Infections in Hospitalized Adults, Louisville, Kentucky, 2010-2013. Open Forum Infect Dis 2020;7:ofaa262. [PMID: 32715020 DOI: 10.1093/ofid/ofaa262] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Kucukoglu K, Faydalı N, Bul D. What are the drugs having potential against COVID-19? Med Chem Res 2020;:1-21. [PMID: 32929317 DOI: 10.1007/s00044-020-02625-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tenforde MW, Talbot HK, Trabue CH, Gaglani M, McNeal TM, Monto AS, Martin ET, Zimmerman RK, Silveira FP, Middleton DB, Olson SM, Garten Kondor RJ, Barnes JR, Ferdinands JM, Patel MM; Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) Investigators . Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019-2020. J Infect Dis 2021;224:813-20. [PMID: 33378531 DOI: 10.1093/infdis/jiaa800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chow EJ, Tenforde MW, Rolfes MA, Lee B, Chodisetty S, Ramirez JA, Fry AM, Patel MM. Differentiating severe and non-severe lower respiratory tract illness in patients hospitalized with influenza: Development of the Influenza Disease Evaluation and Assessment of Severity (IDEAS) scale. PLoS One 2021;16:e0258482. [PMID: 34673782 DOI: 10.1371/journal.pone.0258482] [Reference Citation Analysis]
6 Valerio V, Bazan MC, Wang M, Mazer BD, Pineau CA, Hazel EM, Bernatsky S, Ward BJ, Colmegna I. A multimodal intervention increases influenza vaccine uptake in rheumatoid arthritis. Clin Rheumatol 2021;40:575-9. [PMID: 33030631 DOI: 10.1007/s10067-020-05435-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Wang L, Xia Z, Tang W, Sun Y, Wu Y, Kwok HF, Sun F, Cao Z. p38 activation and viral infection. Expert Rev Mol Med 2022;24. [DOI: 10.1017/erm.2021.29] [Reference Citation Analysis]
8 Lai X, Wang J, Duan J, Gong Y, Cao J. Apoptosis inhibitor of macrophage differentiates bacteria from influenza or COVID-19 in hospitalized adults with community-acquired pneumonia. J Infect 2021:S0163-4453(21)00640-X. [PMID: 34954255 DOI: 10.1016/j.jinf.2021.12.027] [Reference Citation Analysis]
9 Moghnieh R, Abdallah D, Bizri AR. COVID-19: Second Wave or Multiple Peaks, Natural Herd Immunity or Vaccine - We Should be Prepared. Disaster Med Public Health Prep 2020;:1-8. [PMID: 32907693 DOI: 10.1017/dmp.2020.349] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
10 Osorio-López EA, Rivera-Buendía F, Nevárez-Luján J, Rivas-Pichon E, Vilar-Compte D. Nosocomial influenza in patients with cancer before the coronavirus disease 2019 (COVID-19) era and one year after the pandemic: Can we do any better in hospitals? Infect Control Hosp Epidemiol 2021;:1-3. [PMID: 34287115 DOI: 10.1017/ice.2021.337] [Reference Citation Analysis]
11 Teixeira TA, Oliveira YC, Bernardes FS, Kallas EG, Duarte-Neto AN, Esteves SC, Drevet JR, Hallak J. Viral infections and implications for male reproductive health. Asian J Androl 2021;23:335-47. [PMID: 33473014 DOI: 10.4103/aja.aja_82_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 D'Abramo A, Lepore L, Palazzolo C, Barreca F, Liuzzi G, Lalle E, Nicastri E. Acute respiratory distress syndrome due to SARS-CoV-2 and Influenza A co-infection in an Italian patient: Mini-review of the literature. Int J Infect Dis 2020;97:236-9. [PMID: 32565366 DOI: 10.1016/j.ijid.2020.06.056] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
13 Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID-19): a clinical update. Front Med 2020;14:126-35. [PMID: 32240462 DOI: 10.1007/s11684-020-0767-8] [Cited by in Crossref: 155] [Cited by in F6Publishing: 132] [Article Influence: 77.5] [Reference Citation Analysis]
14 Tsai MJ, Yang KY, Chan MC, Kao KC, Wang HC, Perng WC, Wu CL, Liang SJ, Fang WF, Tsai JR, Chang WA, Chien YC, Chen WC, Hu HC, Lin CY, Chao WC, Sheu CC; for Taiwan Severe Influenza Research Consortium (TSIRC) Investigators. Impact of corticosteroid treatment on clinical outcomes of influenza-associated ARDS: a nationwide multicenter study. Ann Intensive Care 2020;10:26. [PMID: 32107651 DOI: 10.1186/s13613-020-0642-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
15 Wang TH, Jheng JC, Tseng YT, Chen LF, Chung JY. National Early Warning Score for predicting intensive care unit admission among elderly patients with influenza infections in the emergency department: an effective disposition tool during the influenza season. BMJ Open 2021;11:e044496. [PMID: 34117044 DOI: 10.1136/bmjopen-2020-044496] [Reference Citation Analysis]
16 Kovacevic P, Matijasevic J, Dragic S, Zlojutro B, Gavrilovic S, Jandric M, Andrijevic A, Kovacevic T, Carapic V, Travar M, Preradovic L, Momcicevic D. Characteristics and outcomes of critically ill patients with influenza A (H1N1) in the Western Balkans during the 2019 post-pandemic season. Indian J Med Microbiol 2020;38:415-20. [PMID: 33154256 DOI: 10.4103/ijmm.IJMM_20_169] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, Péré H, Charbit B, Bondet V, Chenevier-Gobeaux C, Breillat P, Carlier N, Gauzit R, Morbieu C, Pène F, Marin N, Roche N, Szwebel TA, Merkling SH, Treluyer JM, Veyer D, Mouthon L, Blanc C, Tharaux PL, Rozenberg F, Fischer A, Duffy D, Rieux-Laucat F, Kernéis S, Terrier B. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 2020;369:718-24. [PMID: 32661059 DOI: 10.1126/science.abc6027] [Cited by in Crossref: 856] [Cited by in F6Publishing: 841] [Article Influence: 428.0] [Reference Citation Analysis]
18 Paramsothy A, Lartey Jalloh S, Davies RA, Guttormsen AB, Cox RJ, Mohn KG. Humoral and cellular immune responses in critically ill influenza A/H1N1-infected patients. Scand J Immunol 2021;94:e13045. [PMID: 33891354 DOI: 10.1111/sji.13045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Izquierdo JL, Almonacid C, González Y, Del Rio-Bermudez C, Ancochea J, Cárdenas R, Lumbreras S, Soriano JB. The impact of COVID-19 on patients with asthma. Eur Respir J 2021;57:2003142. [PMID: 33154029 DOI: 10.1183/13993003.03142-2020] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 29.0] [Reference Citation Analysis]
20 Aghbash PS, Eslami N, Shirvaliloo M, Baghi HB. Viral coinfections in COVID-19. J Med Virol 2021;93:5310-22. [PMID: 34032294 DOI: 10.1002/jmv.27102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Akkanti BH, Hussain R, Patel MK, Patel JA, Dinh K, Zhao B, Elzamly S, Pelicon K, Petek K, Salas de Armas IA, Akay M, Kar B, Gregoric ID, Buja LM. Deadly combination of Vaping-lnduced lung injury and Influenza: case report. Diagn Pathol 2020;15:83. [PMID: 32646452 DOI: 10.1186/s13000-020-00998-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zhavoronkov A. Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections. Aging (Albany NY) 2020;12:6492-510. [PMID: 32229705 DOI: 10.18632/aging.102988] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 17.0] [Reference Citation Analysis]
23 Yang W, Bai X, Li H, Li H, Fan W, Zhang H, Liu W, Sun L. Influenza A and B Virus-Triggered Epithelial–Mesenchymal Transition Is Relevant to the Binding Ability of NA to Latent TGF-β. Front Microbiol 2022;13:841462. [DOI: 10.3389/fmicb.2022.841462] [Reference Citation Analysis]
24 Lin CH, Chen CH, Hong SY, Lin SS, Chou IC, Lin HC, Chang JS. Comparison of severe pediatric complicated influenza patients with and without neurological involvement. Medicine (Baltimore) 2021;100:e25716. [PMID: 33907160 DOI: 10.1097/MD.0000000000025716] [Reference Citation Analysis]
25 Han Q, Wen X, Wang L, Han X, Shen Y, Cao J, Peng Q, Xu J, Zhao L, He J, Yuan H. Role of hematological parameters in the diagnosis of influenza virus infection in patients with respiratory tract infection symptoms. J Clin Lab Anal 2020;34:e23191. [PMID: 31901184 DOI: 10.1002/jcla.23191] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
26 Zhou HX, Li RF, Wang YF, Shen LH, Cai LH, Weng YC, Zhang HR, Chen XX, Wu X, Chen RF, Jiang HM, Wang C, Yang M, Lu J, Luo XD, Jiang Z, Yang ZF. Total alkaloids from Alstonia scholaris inhibit influenza a virus replication and lung immunopathology by regulating the innate immune response. Phytomedicine 2020;77:153272. [PMID: 32702592 DOI: 10.1016/j.phymed.2020.153272] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
27 Aira C, Klett-Mingo JI, Ruiz T, Garcia-Sacristán A, Martín-Valls GE, Mateu E, Gómez-Laguna J, Rueda P, González VM, Rodríguez MJ, López L. Development of an antigen Enzyme-Linked AptaSorbent Assay (ELASA) for the detection of swine influenza virus in field samples. Anal Chim Acta 2021;1181:338933. [PMID: 34556218 DOI: 10.1016/j.aca.2021.338933] [Reference Citation Analysis]
28 Menzella F, Matucci A, Vultaggio A, Barbieri C, Biava M, Scelfo C, Fontana M, Facciolongo NC. COVID-19: general overview, pharmacological options and ventilatory support strategies. Multidiscip Respir Med 2020;15:708. [PMID: 33282284 DOI: 10.4081/mrm.2020.708] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Mirzaei R, Abdi M. An influenza A outbreak in Iranian individuals following Arba'een foot pilgrimage from October to December 2019. Infect Control Hosp Epidemiol 2020;41:627-8. [PMID: 32160936 DOI: 10.1017/ice.2020.49] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Yang J, Zhang B, Huang Y, Liu T, Zeng B, Chai J, Wu J, Xu X. Antiviral activity and mechanism of ESC-1GN from skin secretion of hylarana guentheri against influenza a virus. J Biochem 2021:mvab019. [PMID: 33624755 DOI: 10.1093/jb/mvab019] [Reference Citation Analysis]
31 Javanian M, Barary M, Ghebrehewet S, Koppolu V, Vasigala V, Ebrahimpour S. A brief review of influenza virus infection. J Med Virol 2021;93:4638-46. [PMID: 33792930 DOI: 10.1002/jmv.26990] [Reference Citation Analysis]
32 Zou Q, Zheng S, Wang X, Liu S, Bao J, Yu F, Wu W, Wang X, Shen B, Zhou T, Zhao Z, Wang Y, Chen R, Wang W, Ma J, Li Y, Wu X, Shen W, Xie F, Vijaykrishna D, Chen Y. Influenza A-associated severe pneumonia in hospitalized patients: Risk factors and NAI treatments. Int J Infect Dis. 2020;92:208-213. [PMID: 31978583 DOI: 10.1016/j.ijid.2020.01.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
33 Honore PM, Kugener L, Redant S, Attou R, Gallerani A, De Bels D. Treatment of influenza virus-related critical illness during continuous renal replacement therapy: take caution with dosing. Crit Care 2020;24:72. [PMID: 32127029 DOI: 10.1186/s13054-020-2813-y] [Reference Citation Analysis]
34 Lui JK, Mesfin N, Tugal D, Klings ES, Govender P, Berman JS. Critical Care of Patients With Cardiopulmonary Complications of Sarcoidosis. J Intensive Care Med 2021;:885066621993041. [PMID: 33611981 DOI: 10.1177/0885066621993041] [Reference Citation Analysis]
35 Janik E, Ceremuga M, Niemcewicz M, Bijak M. Dangerous Pathogens as a Potential Problem for Public Health. Medicina (Kaunas) 2020;56:E591. [PMID: 33172013 DOI: 10.3390/medicina56110591] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Wang Y, Fan G, Salam A, Horby P, Hayden FG, Chen C, Pan J, Zheng J, Lu B, Guo L, Wang C, Cao B. Comparative Effectiveness of Combined Favipiravir and Oseltamivir Therapy Versus Oseltamivir Monotherapy in Critically Ill Patients With Influenza Virus Infection. J Infect Dis. 2020;221:1688-1698. [PMID: 31822885 DOI: 10.1093/infdis/jiz656] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 56.0] [Reference Citation Analysis]
37 Tenforde MW, Chung J, Smith ER, Talbot HK, Trabue CH, Zimmerman RK, Silveira FP, Gaglani M, Murthy K, Monto AS, Martin ET, McLean HQ, Belongia EA, Jackson LA, Jackson ML, Ferdinands JM, Flannery B, Patel MM. Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015-2018. Clin Infect Dis 2021;73:386-92. [PMID: 32270198 DOI: 10.1093/cid/ciaa407] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
38 Horio Y, Sogabe R, Shichiri M, Ishida N, Morimoto R, Ohshima A, Isegawa Y. Induction of a 5-lipoxygenase product by daidzein is involved in the regulation of influenza virus replication. J Clin Biochem Nutr 2020;66:36-42. [PMID: 32001954 DOI: 10.3164/jcbn.19-70] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 [DOI: 10.1101/2020.04.19.20068015] [Cited by in Crossref: 95] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
40 Takia L, Saini L, Keshavan S, Angurana SK, Nallasamy K, Suthar R, Verma S, Singh P, Goyal K, Ratho RK, Jayashree M. Neurological Manifestations of Influenza A (H1N1): Clinical Features, Intensive Care Needs, and Outcome. Indian J Pediatr 2020;87:803-9. [PMID: 32358785 DOI: 10.1007/s12098-020-03297-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Hooshmand E, Moa A, Trent M, Kunasekaran M, Poulos CJ, Chughtai AA, MacIntyre CR. Epidemiology of 2017 influenza outbreaks in nine Australian Aged care facilities. Influenza Other Respir Viruses 2021;15:278-83. [PMID: 33026149 DOI: 10.1111/irv.12811] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Menzella F, Biava M, Barbieri C, Livrieri F, Facciolongo N. Pharmacologicaltreatment of COVID-19: lights and shadows. Drugs Context 2020;9:2020-4-6. [PMID: 32499832 DOI: 10.7573/dic.2020-4-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
43 Wautlet AJ, Patel PD, Chavez P, Codispoti CD. Influenza epidemics: The role of allergists-immunologists. Ann Allergy Asthma Immunol 2021;126:350-6. [PMID: 33259922 DOI: 10.1016/j.anai.2020.11.012] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Zanettini C, Omar M, Dinalankara W, Imada EL, Colantuoni E, Parmigiani G, Marchionni L. Influenza Vaccination and COVID-19 Mortality in the USA: An Ecological Study. Vaccines (Basel) 2021;9:427. [PMID: 33923159 DOI: 10.3390/vaccines9050427] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
45 Babaei A, Mousavi SM, Ghasemi M, Pirbonyeh N, Soleimani M, Moattari A. Gold nanoparticles show potential in vitro antiviral and anticancer activity. Life Sci 2021;:119652. [PMID: 34051217 DOI: 10.1016/j.lfs.2021.119652] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Torres A, Loeches IM, Sligl W, Lee N. Severe flu management: a point of view. Intensive Care Med 2020;46:153-62. [PMID: 31912206 DOI: 10.1007/s00134-019-05868-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
47 O'Sullivan S, Torres A, Rodriguez A, Martin-Loeches I. Influenza management with new therapies. Curr Opin Pulm Med 2020;26:215-21. [PMID: 32068576 DOI: 10.1097/MCP.0000000000000667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
48 Watson A, Wilkinson TMA. Respiratory viral infections in the elderly. Ther Adv Respir Dis 2021;15:1753466621995050. [PMID: 33749408 DOI: 10.1177/1753466621995050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
49 Song Z, Jia X, Bao J, Yang Y, Zhu H, Shi X. Spatio-Temporal Analysis of Influenza-Like Illness and Prediction of Incidence in High-Risk Regions in the United States from 2011 to 2020. Int J Environ Res Public Health 2021;18:7120. [PMID: 34281057 DOI: 10.3390/ijerph18137120] [Reference Citation Analysis]
50 Perricone C, Triggianese P, Bartoloni E, Cafaro G, Bonifacio AF, Bursi R, Perricone R, Gerli R. The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19. J Autoimmun. 2020;111:102468. [PMID: 32317220 DOI: 10.1016/j.jaut.2020.102468] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 30.5] [Reference Citation Analysis]
51 Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the Nervous System. Cell 2020;183:16-27.e1. [PMID: 32882182 DOI: 10.1016/j.cell.2020.08.028] [Cited by in Crossref: 134] [Cited by in F6Publishing: 141] [Article Influence: 67.0] [Reference Citation Analysis]
52 Yi M, Lin S, Zhang B, Jin H, Ding L. Antiviral potential of natural products from marine microbes. Eur J Med Chem 2020;207:112790. [PMID: 32937282 DOI: 10.1016/j.ejmech.2020.112790] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
53 Febbo J, Revels J, Ketai L. Viral Pneumonias. Radiologic Clinics of North America 2022;60:383-97. [DOI: 10.1016/j.rcl.2022.01.010] [Reference Citation Analysis]
54 Li Y, He H, Gao Y, Ou Z, He W, Chen C, Fu J, Xiong H, Chen Q. Comparison of Clinical Characteristics for Distinguishing COVID-19 From Influenza During the Early Stages in Guangdong, China. Front Med (Lausanne) 2021;8:733999. [PMID: 34859002 DOI: 10.3389/fmed.2021.733999] [Reference Citation Analysis]
55 Li J, Li S, Qiu X, Zhu W, Li L, Qin B. Performance of Diagnostic Model for Differentiating Between COVID-19 and Influenza: A 2-Center Retrospective Study. Med Sci Monit 2021;27:e932361. [PMID: 33976103 DOI: 10.12659/MSM.932361] [Reference Citation Analysis]
56 Slain D. Intravenous Zanamivir: A Viable Option for Critically Ill Patients With Influenza. Ann Pharmacother 2021;55:760-71. [DOI: 10.1177/1060028020963616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Asseri AA, Shati AA, Al-Qahtani SM, Alzaydani IA, Al-Jarie AA, Alaliani MJ, Ali AS. Distinctive clinical and laboratory features of COVID-19 and H1N1 influenza infections among hospitalized pediatric patients. World J Pediatr 2021;17:272-9. [PMID: 33970449 DOI: 10.1007/s12519-021-00432-1] [Reference Citation Analysis]
58 Qiu L, Wu XW, Zhang SY, Yang M, Zhang SX, Fu JY, Li C, Zhang ZJ, Zheng PY, Lu ZH. Evaluation of efficacy and safety of Qiangzhu-qinggan formula as an adjunctive therapy in adult patients with severe influenza: study protocol for a randomized parallel placebo-controlled double-blind multicenter trial. Trials 2021;22:955. [PMID: 34961550 DOI: 10.1186/s13063-021-05929-8] [Reference Citation Analysis]
59 Yan J, Liu A, Huang J, Wu J, Fan H. Research Progress of Drug Treatment in Novel Coronavirus Pneumonia. AAPS PharmSciTech 2020;21:130. [PMID: 32405780 DOI: 10.1208/s12249-020-01679-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Walkowski W, Bassett J, Bhalla M, Pfeifer BA, Ghanem ENB. Intranasal Vaccine Delivery Technology for Respiratory Tract Disease Application with a Special Emphasis on Pneumococcal Disease. Vaccines (Basel) 2021;9:589. [PMID: 34199398 DOI: 10.3390/vaccines9060589] [Reference Citation Analysis]
61 Cizeron A, Saunier F, Gagneux-Brunon A, Pillet S, Cantais A, Botelho-Nevers E. Low rate of oseltamivir prescription among adults and children with confirmed influenza illness in France during the 2018-19 influenza season. J Antimicrob Chemother 2021;76:1057-62. [PMID: 33406225 DOI: 10.1093/jac/dkaa539] [Reference Citation Analysis]
62 Masterson CH, Ceccato A, Artigas A, Dos Santos C, Rocco PR, Rolandsson Enes S, Weiss DJ, McAuley D, Matthay MA, English K, Curley GF, Laffey JG. Mesenchymal stem/stromal cell-based therapies for severe viral pneumonia: therapeutic potential and challenges. Intensive Care Med Exp 2021;9:61. [PMID: 34970706 DOI: 10.1186/s40635-021-00424-5] [Reference Citation Analysis]